Left Right

Michael C. Barnes’s Speaking Engagements and Publications

Speaking Engagements:

Human Abuse Liability & Abuse-Deterrent Formulations Conference
November 2, 2016
Arlington, VA
“Essential Elements of Legislation to Foster a Transition to Medications with Abuse-Deterrent Properties”
Plenary Presenter

National Association of State Controlled Substances Authorities Annual Conference
October 20, 2016
New Orleans, LA
“Science, Not Stigma, Should Drive Policy: An Update on Medications with Abuse-Deterrent Properties”
Presenter

PAINWeek 2016 National Conference
September 9-10, 2016
Las Vegas, NV
“Trends in Federal and State Policy and Their Impacts on Pain Management”
Faculty
“Managing the Risks of Prescribing Controlled Medications”
Faculty

American Society for Pain Management Nursing (ASPMN) 26th National Conference
September 8, 2016
Louisville, KY
“A Call for Balance in Pain Care & Prescription Drug Abuse Prevention: Legislation & Policy”
Presenter, Panelist

Congressional Roundtable on Opioids (U.S. Rep. Ryan Costello, PA-6)
July 26, 2016
Pottstown, PA
“Compassion, Not Contempt: The Essential Elements of Opioid-Related Policies”
Presenter, Panelist

International Conference on Opioids
June 6, 2016
Boston, MA
“If Not You, Who? A Call for Informed Professionals To Engage in Opioid-Related Policy Making”
Presenter

National Conference of State Legislatures
May 14, 2016
New Orleans, LA
“The Realities of Pain: Treatments, Costs, Challenges, and Solutions”
Faculty
“Innovations in Pain Management”
Faculty

Alliance for the Adoption of Innovations in Medicine
May 13, 2016
Washington, DC
“Closing Legal Loopholes To Improve Health Care”
Moderator

Broward Behavioral Health Conference: Building Healthier Communities
May 10, 2016
Fort Lauderdale, FL
“Engaging Policy Makers To Advance Compassion and Eliminate Contempt in Behavioral Health Policy”
Presenter

Millennium Health Educational Program
April 14, 2016
Webcast
“Urine Drug Testing in Substance Use Disorder Treatment: A Consensus-Based Ethical Approach”
Presenter

New York State Pain Society
April 1-3, 2016
West Harrison, NY
“Establishing Clinically Rational and Ethically Sound Urine Drug Testing Protocols”
Presenter

National Prescription Drug Abuse and Heroin Summit
March 28-31, 2016
Atlanta, GA
“Buprenorphine: Knocking Out Pill Mills and Minimizing Diversion”
Presenter
“Addiction Is a Disease, Not a Choice, and Should Be Treated As Such”
Moderator
“Best Practices in Treating Opioid Addiction in the Criminal Justice Population”
Moderator
“Advances in Treating Chronic Pain and Addiction”
Moderator

Abuse-Deterrent Formulations Summit
March 9-10, 2016
Alexandria, VA
“The Impacts of Federal and State Policy on the Development and Use of Abuse-Deterrent Medications”
Presenter

Addiction Executives Industry (aXis) Summit
January 31-February 3, 2016
Naples, FL
“Legal, Policy, and Ethical Issues in Addiction Treatment”
Keynote Presenter

The Pain Society of the Carolinas
January 30, 2016
Charleston, SC
“Establishing Clinically Rational & Ethically Sound UDT Protocols”
Presenter

Providers’ Clinical Support System for Opioid Therapies
January 27, 2016
Webinar
“Pain Care and Prescription Drug Abuse: Current Topics, Legislation, and Policy”
Presenter

National Prescription Drug Abuse Prevention Policy Meeting
December 1, 2015
Washington, DC
“Protecting Americans’ Health, Economy, and Values”
Moderator, Presenter

Human Abuse Liability & Abuse-Deterrent Formulations Conference
November 3, 2015
Bethesda, MD
“Defining the Next Generation of Abuse Deterrence Techniques”
Presenter

NAADAC: The Association for Addiction Professionals 2015 Annual Conference
October 11, 2015
Bethesda, MD
“Urine Drug Testing in Addiction Medicine: A New Paradigm to Improve Outcomes and Reduce Costs”
Presenter

American Society for Pain Management Nursing (ASPMN) 25th National Conference
September 19, 2015
Atlanta, Georgia
“Pain Care & Prescription Drug Abuse: Current Topics, Legislation, & Policy”
Presenter, Panelist

Higher Education Center for Alcohol and Drug Misuse Prevention and Recovery National Meeting
August 5, 2015
Columbus, OH
“Non-Medical Use of Prescription Medications Among College Students”
Panelist

State Pain Policy Advocacy Network Leadership Advisory Council Meeting
August 4, 2015
Overland Park, KS
“Federal Issues and Trends”
Presenter

Rutgers University Summer School of Addiction Studies
July 8, 2015
New Brunswick, NJ
“Implications of Policy on Professional Practice”
Lecturer

International Conference on Opioids
June 8-9, 2015
Boston, MA
“Improving Utilization and Outcomes of Urine Drug Testing”
Presenter
“Legal Issues from a Physician’s Viewpoint”
Panelist

American Society of Addiction Medicine 46th Annual Conference
April 25, 2015
Austin, TX
“Safer Prescribing of Controlled Substances: A Legal Perspective”
Presenter

National Rx Drug Abuse Summit
April 6-9, 2015
Atlanta, GA
“Emerging Medical and Legal Issues”
Presenter, Panelist
“Optimizing Utilization and Outcomes of Urine Drug Testing”
Presenter, Panelist
“Evolution of Diagnosis and Treatment Options”
Moderator
“Parent Advocates Moving Legislation”
Moderator

Innovations in Recovery
March 30, 2015
Coronado, CA
“Improving Outcomes and Preventing Practitioner Liability in Urine Drug Testing”
Presenter, Panelist

The Notre Dame Journal of Law, Ethics & Public Policy Symposium on Regulating Life, Disease, and Death
March 19, 2015
Notre Dame, Indiana
“Applying Lessons from the Opioid Abuse Epidemic To Protect Consumers from Black Market Prescription Drugs”
Presenter, Panelist

Addiction Executives Industry Summit (aXis) 
February 8-11, 2015
Naples, FL
“Executive Update on Law and Policy Affecting Addiction Treatment”
Keynote Presenter

National Prescription Drug Abuse Prevention Policy Meeting
December 2, 2014
Washington, DC
“Refining Policy To Mitigate Unintended Consequences, Improve Access to Care, and Uphold Core Values”
Moderator, Presenter

International Nurses Society on Addictions
October 16, 2014
Washington, DC
“Addressing an Evolving Epidemic through Substance Use Intervention and Treatment Policies”
Presenter

American Society for Pain Management Nursing 24th National Conference
September 19, 2014
San Diego, CA
“Addressing an Evolving Epidemic through Substance Use Intervention and Treatment Policies”
Presenter

27th Annual Cape Cod Symposium on Addictive Disorders
September 11-14, 2014
Hyannis, MA
“The Definitive Marijuana Discussion: A Historical Review, Situational Analysis, and Future Projection”
Presenter, Panelist
“Achieving Real Parity: Enforcing the Mental Health Parity and Addiction Equity Act and the Patient Protection and Affordable Care Act to Ensure Access to Substance Abuse Treatment”
Presenter
“Proper Utilization of Urine Testing in Identifying and Treating Substance Use Disorders”
Presenter, Panelist

Generation Rx University Conference
August 7, 2014
Columbus, OH
“From Campuses to Capitals: Activating the Recovery Community to Address Evolving Trends in Substance Use”
Presenter

National Association of Attorneys General Summer Meeting
June 2, 2014
Mackinac Island, MI
“Prescription Drug Monitoring Programs: An Exploration of Best Practices and Opportunities for Collaboration”
Presenter, Panelist

National Rx Drug Abuse Summit
April 22-24, 2014
Atlanta, GA
“Avoiding the Dangers of Rumor-Based Medicine”
Moderator
“Integrating PDMP Data Into the Clinical Workflow”
Moderator

National Association of Attorneys General Southern Region Meeting
April 2, 2014
Savannah, GA
Prescription Drug Abuse: Legal Strategies to Curb the Evolution of the Epidemic
Presenter

Congressional News Conference
March 15, 2013
U.S. Capitol, Washington, DC
Remarks in support of the STOPP Act, a House bill to reduce prescription drug abuse by fostering a market transition to abuse-deterrent medications.

University of Arkansas Law Review Symposium
February 28, 2014
Little Rock, AR
“Choices and Consequences: Health Policy and the Affordable Care Act”
Presenter

West Virginia Law Review Symposium
February 13, 2014
Morgantown, WV
“Prescription Drug Abuse: The Law’s Struggle To Address an Epidemic”
Presenter

Addiction Executives Industry  Summit (aXis)
February 9-11, 2014
Naples, FL
Facilitator

National Sheriffs’ Association 2014 Winter Conference
January 24, 2014
Washington, DC
“Prescription Drug Fraud, Diversion, and Abuse: Policies To Address the Evolving Epidemic”
Presenter

National Prescription Drug Abuse Prevention Policy Consensus Meeting
November 19, 2013
Washington, DC
Moderator and Presenter

National Association of Drug Diversion Investigators
November 6, 2013
Webinar
“Prescription Drug Abuse: Trends in Law and Policy”
Presenter

International Conference on Opioids: Basic Science, Clinical Application & Compliance
June 11, 2013
Boston, MA
“Trends in Law and Policy Affecting Opioid Prescribing”
Presenter

RADARS System Seventh Annual Scientific Meeting: Formulating a Solution to Misuse and Abuse
April 18, 2013
Rockville, MD
“Prescription Drug Abuse Prevention Policy Priorities”
Presenter

National Rx Drug Abuse Summit
April 2-4, 2013
Orlando, FL
“Examining Prescription Drug Abuse from Federal, State, Community, and Campus Perspectives”
Moderator
“Risk, Recognize, Resolve: Addiction in the Pharmacy Profession”
Moderator

National Prescription Drug Abuse Prevention Policy Consensus Meeting
November 27, 2012
Washington, DC
Moderator, Presenter

Delaware Prescription Drug Abuse Summit
November 16, 2012
Newark, DE
National Prescription Drug Abuse Prevention Strategy

Pennsylvania House of Representatives
Committee on Professional Licensure
September 18, 2012
Harrisburg, PA
Prescription Drug Abuse Prevention Policy, H.B. 1635 Proponent (by Invitation of Committee Chairwoman)

PAINWeek 2012 National Conference
September 8, 2012
Las Vegas, NV
“Current Events in Law and Policy: Implications for Pain Care Practitioners”
Faculty

Congressional News Conference
July 19, 2012
U.S. Capitol, Washington, DC
Remarks in support of the STOPP Act, a House bill to reduce prescription drug abuse by removing traditional opioids from the market after abuse-deterrent versions of them are approved.

National Rx Drug Abuse Summit
April 10-12, 2012
Orlando, FL
“National Dialogue on Drug-Impaired Driving”
Presenter
“Examining What’s Happening across America”
Moderator
“The Financial Impact of Prescription Drug Abuse on Employers”
Moderator

Tennessee House of Representatives
Committee on Health and Human Resources
March 13, 2012
Nashville, TN
Prescription Drug Abuse Prevention Policy, H.B. 2567 Proponent (by Invitation of Bill Sponsor)

Kentucky House of Representatives
Committee on Health and Welfare
February 23, 2012
Frankfort, KY
Prescription Drug Abuse Prevention Policy, H.B. 377 Proponent (by Invitation of Bill Sponsor)

Ohio House of Representatives
Committee on Health and Aging
January 25, 2012
Columbus, OH
Prescription Drug Abuse Prevention Policy, H.B. No. 373 Proponent (by Invitation of Bill Sponsor)

New Jersey Assembly
Health and Senior Services Committee
November 21, 2011
Trenton, NJ
Prescription Drug Abuse Prevention Policy, A4041 Proponent (by Invitation of Bill Sponsor)

National Prescription Drug Abuse Prevention Policy Consensus Meeting
November 29, 2011
Washington, DC
Moderator

National Sheriffs’ Association
2011 Winter Conference
January 7, 2011
Palm Desert, CA
“Suggestions for Sheriffs Seeking To Protect Their Communities from Prescription Drug Abuse”
Drug Enforcement Session

National Prescription Drug Abuse Prevention Policy Consensus Meeting
November 30, 2010
Washington, DC
Moderator

American Society for Pain Management Nursing
20th National Conference, Expanding the Boundaries of Pain Management Nursing: The Next 20 Years
September 22-25, 2010
Minneapolis, Minnesota
“What, You Thought REMS Was All About Sleep? Ain’t Necessarily So!”
Workshop

Congressional Forum on Prescription Drug Abuse
U.S. House of Representatives Caucus on Prescription Drug Abuse
September 22, 2010
U.S. Capitol, Washington, District of Columbia
“Recommendations for Prescription Monitoring Program Optimization”
Presenter, Panelist

Alliance of States with Prescription Monitoring Programs (ASPMP)
Harold Rogers Prescription Drug Monitoring Program National Meeting
June 28-30, 2010
Washington, District of Columbia
“Merging Federal and State Policies To Address Prescription Drug Abuse”
Plenary

The National Association of Triads
National Triad Conference
December 10, 2009
Orlando, Florida
“Preventing Prescription Drug Abuse: Law Enforcement’s Role in Addressing a Public Health Problem”
Workshop

National Prescription Drug Abuse Prevention Policy Consensus Meeting
December 1, 2009
Washington, DC
Moderator

Alliance of State Pain Initiatives (ASPI)
20 Annual Meeting of the Alliance of State Pain Initiatives:Bridging the Gaps in Pain Care
October 23-25, 2009
San Francisco, California
“A Vital Balancing Act: Preventing Prescription Drug Abuse while Ensuring Patient Access”
Workshops

Tuft’s Health Care Institute Program on Opioid Risk Management
Conference on Prescription Monitoring
April 2, 2009
Boston, Massachusetts
State and Federal Prescription Monitoring Programs

National Prescription Drug Abuse Prevention Policy Consensus Meeting
July 28, 2008
Washington, DC
Moderator

The National Association of Therapeutic Schools and Programs (NATSAP)
NATSAP Annual Meeting
January 31-February 2, 2007
La Jolla, California
“Legislation, Politics, and Advocacy”
Workshop

Publications:

Michael C. Barnes, et al., What’s in a Number? Recommending Practicality in the DATA 2000 Patient Limits, 12 J. Opioid Manag. 243 (2016).

Michael C. Barnes, et al., A Call for Differential Diagnosis of Non-Specific Low Back Pain to Reduce Opioid Abuse, 101 J. of Med. Reg. 39 (2015).

Michael C. Barnes & Stacey L. Worthy, Evaluating Motives: Two Simple Tests to Identify and Avoid Entanglement in Legally Dubious Urine Drug Testing Schemes, 11 J. Opioid Manag. 89 (2015).

Kyle Simon, et al., Abuse-Deterrent Formulations: Transitioning the Pharmaceutical Market to Improve Public Health and Safety, 6 Therapeutic Advances in Drug Safety 1 (2015).

Michael C. Barnes & Stacey L. Worthy, Achieving Real Parity: Increasing Access to Treatment for Substance Use Disorders Under the Patient Protection and Affordable Care Act and the Mental Health and Addiction Equity Act, 36 U Ark Little Rock L. Rev. 555 (2015).

Michael C. Barnes & Stacey L. Sklaver, Applying Lessons from the Opioid Abuse Epidemic to Protect Consumers from Gray Market Biologics, Notre Dame J.L. Ethics & Pub. Pol’y (2015).

Michael C. Barnes & Gretchen Arndt, The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse. Md. J. Health Care L. & Pol’y (2013).

Michael C. Barnes & Stacey L. Sklaver, Active Verification and Vigilance: A Method To Avoid Civil and Criminal Liability When Prescribing Controlled Substances, DePaul J. Health Care L. (2013).

Michael C. Barnes & Gretchen Arndt, The Best of Both Worlds: Applying Federal Commerce and State Police Powers To Reduce Prescription Drug Abuse. Md. J. Health Care L. & Pol’y. (2013).

Michael C. Barnes & Marina Hench, National Prescription Drug Abuse Prevention Strategy: 2011-2012 Update, Center for Lawful Access and Abuse Deterrence, available at http://www.claad.org/resources/national-strategy.

Michael C. Barnes, et al., National Prescription Drug Abuse Prevention Strategy 2010, Center for Lawful Access and Abuse Deterrence, available at http://www.claad.org/resources/national-strategy.

Michael C. Barnes, et al., National Prescription Drug Abuse Prevention Strategy 2009, Center for Lawful Access and Abuse Deterrence, available at http://claad.org/downloads/Nat_Prescipt_Drug_Abuse_Prev_Strat_2009.pdf.

Michael C. Barnes, et al., A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1 & Part 2, J. on Global Drug Pol’y & Prac. Vol. 3, Issue 4 (Winter 2010).